CD209 and cancer: As shown in Figure 8B, many immune related molecules such as CCL18, CD209, C3AR1, CLEC4D, CLEC7A, CMKLR1, CD86, CYSLTR2, TLR8 and CCR2 were consistent with CD163, suggesting CD163 expressed in cancer cells may also be involved in tumor immune evasion.